Morgan Stanley Raises China Humanoid Robot 2026 Shipment Forecast to 50,000 Units
0xBroomberg
Morgan Stanley nearly doubled its 2026 China humanoid robot shipment forecast from 28,000 to 50,000 units, targeting 446,000 by 2030 — a five-year CAGR of 106%. Real orders, aggressive policy mandates, and a supply chain scaling far ahead of demand are all flashing green at once.
Why did Morgan Stanley nearly double the forecast in one go?
Three signals converged: State Grid's ¥6.8 billion order landed, MIIT and SASAC launched a nationwide deployment mandate, and component makers began doubling monthly capacity.
This means → humanoid robots have crossed from demo stage to real procurement and capex commitments.
In plain terms = the story shifted from "everyone thinks it can be done" to "someone is buying, someone is building factories, and the government set a graded scorecard." All three at once gave Morgan Stanley the confidence to revise up.
Who is putting real money on the table?
State Grid placed a single order covering 500 humanoid robots, 3,000 dual-arm robots, and 5,000 quadruped robots — ¥6.8 billion in total.
SF Express and China Post are deploying Agibot humanoid robots in logistics hubs, among the earliest commercial validation cases.
On the policy side, MIIT requires local governments and central SOEs to identify at least 20 and 10 real operating sites respectively for robot training, with a progress review in November 2026.
This means → demand is not a single buyer — grid, logistics, and policy are advancing in parallel, giving the pipeline more breadth than the market expected.
What type of robot is actually shipping today?
Roughly 70% of current shipments are half-size models (e.g. Unitree G1); full-size humanoids account for about 30%.
Morgan Stanley expects the full-size share to rise steadily: ~50% in 2027, ~70% in 2028.
In plain terms = the workhorse today is the "compact" robot — cheaper, easier to deploy. As the technology matures, full-size units will gradually take over.
This reflects a volume-first, upgrade-later playbook — average selling prices drop 15% in 2026 to push adoption, then recover as the pricier full-size mix grows.
How aggressively is the supply chain scaling?
Leaderdrive (绿的谐波): harmonic reducer — a core joint component — monthly capacity rose from 50,000 in Q1 to 70,000 now, targeting 100,000–120,000 by year-end.
Hengli Hydraulic (恒立液压): Mexico plant aims to support roughly 100,000 robots by year-end.
Xinje (信捷): targeting 2 million frameless torque motor sets this year — the motors that drive joint rotation — and 3 million next year.
This means → the component tier is not "testing the waters" — it is betting big on expansion, with capacity plans that far exceed this year's 50,000 unit shipment target, wagering on a 2027–2028 ramp.
Which stocks does Morgan Stanley favour most?
Leaderdrive (harmonic reducer leader): Morgan Stanley assumes a 40% global humanoid harmonic reducer share in 2026, raised its target price 72% to ¥464, and maintains Overweight.
Hengli Hydraulic: positioned as the key supplier of planetary roller screws — precision components that convert rotary motion into linear motion — with potential to expand into motors and linear actuator assemblies.
ShuangHuan Transmission (双环传动): supplies gears for reducers and has been co-developing a new reducer with a leading U.S. humanoid robot maker for over two years.
The value-chain watchlist added Kedali and Lens Technology, removed Guomao, Xusheng, and Zhongjian due to limited robotics progress. The list now covers 45 stocks in total.
What should investors watch in the second half?
Year-to-date, China's humanoid robot value-chain index is down 11.3%, roughly in line with MSCI China's 12.1% decline — but dispersion is stark: component suppliers fell 8.7%, assemblers 14.9%, and robot "brain" companies 27.2%.
Morgan Stanley flags Q3 as an event-heavy window: Tesla Optimus Gen 3 launch, humanoid robot IPOs, the World AI Conference in July, and the World Robot Conference in August.
In plain terms = prices have already pulled back. The market needs to see real orders and product upgrades before it re-rates — Q3's lineup of events is the "show-your-work" moment.
Content is for reference only, not financial advice.